Evidence map›Paper›PMID 35498069›Full record

ArticleRSC advances2021

Fluorescently labeled xylosides offer insight into the biosynthetic pathways of glycosaminoglycans.

Roberto Mastio, Daniel Willén, Zackarias Söderlund, Gunilla Westergren-Thorsson, Sophie Manner, Emil Tykesson, Ulf Ellervik

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Roberto MastioCentre for Analysis and Synthesis, Centre for Chemistry and Chemical Engineering, Lund University P. O. Box 124 SE-221 00 Lund Sweden ulf.ellervik@chem.lu.se.
Daniel WillénCentre for Analysis and Synthesis, Centre for Chemistry and Chemical Engineering, Lund University P. O. Box 124 SE-221 00 Lund Sweden ulf.ellervik@chem.lu.se.
Zackarias SöderlundDepartment of Experimental Medical Science, Lund University P. O. Box 117 SE-221 00 Lund Sweden.ORCID https://orcid.org/0000-0002-7150-4025
Gunilla Westergren-ThorssonDepartment of Experimental Medical Science, Lund University P. O. Box 117 SE-221 00 Lund Sweden.ORCID https://orcid.org/0000-0001-5327-8805
Sophie MannerCentre for Analysis and Synthesis, Centre for Chemistry and Chemical Engineering, Lund University P. O. Box 124 SE-221 00 Lund Sweden ulf.ellervik@chem.lu.se.
Emil TykessonDepartment of Experimental Medical Science, Lund University P. O. Box 117 SE-221 00 Lund Sweden.ORCID https://orcid.org/0000-0002-0511-9831
Ulf EllervikCentre for Analysis and Synthesis, Centre for Chemistry and Chemical Engineering, Lund University P. O. Box 124 SE-221 00 Lund Sweden ulf.ellervik@chem.lu.se.ORCID https://orcid.org/0000-0001-5287-0137
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five novel xylosides tagged with the fluorescent probe Pacific Blue™ were synthesized and found to act as substrates for β4GalT7, a bottleneck enzyme in the biosynthetic pathways leading to glycosaminoglycans. By confocal microscopy of A549 cells, we showed that the xylosides were taken up by the cells, but did not enter the Golgi apparatus where most of the glycosaminoglycan biosynthesis occurs. Instead, after a possible double galactosylation by β4GalT7 and β3GalT6, the biosynthesis was terminated. We hypothesize this is due to the charge of the fluorescent probe, which is required for fluorescent ability and stability under physiological conditions.

Identifiers

PMID35498069
PMCPMC9044174
OpenAlexW3217022376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.